Christopher Groux is an editor, writer and accessibility advocate. Before joining the Forbes Health team, he covered Accessibility at Reviewed and gaming at Inverse and Newsweek. When he’s not ...
Weight-loss medications continue to grow in popularity as an anti-obesity tool — but are some more effective than others? The question was explored in a new study published this month in The New ...
For many Americans struggling to lose weight, powerful new medications are changing the game. With roughly 40% of U.S. adults living with obesity, according to the Centers for Disease Control ...
Both Zepbound and Ozempic can lead to weight loss, but only Zepbound is FDA-approved for weight loss. Zepbound treats obesity and obstructive sleep apnea; Ozempic treats type 2 diabetes and lowers ...
Ozempic Alternatives for Weight Loss: What Are Your Options? Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss — when a drug ...
Early weight loss ≥ 2% or ≥ 3% by 4 weeks in structured weight-loss programs is significantly associated with achieving ≥ 5% or ≥ 10% total weight loss, respectively, by 16 weeks in adults with class ...
Share on Pinterest The Food and Drug Administration (FDA) recently approved a tablet version of the GLP-1 drug Wegovy for weight loss. Image courtesy of Novo Nordisk Novo Nordisk officials said a new ...
Noom Med is a medically-guided weight loss program that combines clinical care with Noom's behavior-change tools. The program provides virtual consultations, medication management, and nutrition ...
People turning to injectable GLP-1 treatments—a class of drugs that mimics that hormone to control diabetes and promote weight loss—now have another way to take the medication. On Dec. 22, the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results